PR Newswire BiotechOriginal article
Texas Cardiac Arrhythmia Institute at St. David's Medical Center first in U.S. to participate in trial for innovative mapping and pulsed field ablation system
Trial Startmapping and pulsed field ablation systemPositive
AI Analysis
Summary
Texas Cardiac Arrhythmia Institute at St. David's Medical Center became the first U.S. facility to participate in a clinical trial evaluating a next-generation mapping and pulsed field ablation system for cardiac arrhythmia treatment.
Clinical Trial Data
Importance:3/10
Sentiment:
0.30
clinical trialcardiac arrhythmiamedical devicepulsed field ablation
Read the original article
Published by PR Newswire Biotech on September 2, 2026 7:37 AM
